Heart Disease Clinical Trials in Nashville

Showing 221-240 of 246 trials

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

NCT01008670

The primary goal of this study is to develop techniques to identify the course of the phrenic nerve in patients already undergoing cardiac resynchronization therapy (CRT) implantation or candidates for future CRT devices undergoing implantable cardioverter-defibrillator (ICD) or pacemaker implantation. Specifically, the study intends to identify the location and course of the left pericardiophrenic vein, and thus the left phrenic nerve, to guide the location for coronary vein lead placement and minimize the risk of phrenic nerve stimulation.

Heart Failure

Respicardia, Inc.120 participantsStarted Dec 2007

Birmingham, Alabama, United States • Baltimore, Maryland, United States • Cincinnati, Ohio, United States +10 more locations

COMPLETED< 1 mile

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

NCT00180466

PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be enrolled into the study at sites in the United States and European Union.

Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis

Abbott Medical Devices697 participantsStarted Oct 2004

Phoenix, Arizona, United States • San Jose, California, United States • Stanford, California, United States +37 more locations

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Heart Disease Trials in Other Cities

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Attain StarFix™ Model 4195 Left Ventricular Lead

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

The Epidemiology of Ventricular Assist Device-Related Infections

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Biomarkers in Acute Heart Failure

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Other Conditions in Nashville